China Pharma (CPHI) Short Interest Ratio & Short Volume

Short interest is the volume of China Pharma shares that have been sold short but have not yet been closed out or covered. As of July 31st, traders have sold 6,900 shares of CPHI short. 0.30% of China Pharma's shares are currently sold short. Learn More on China Pharma's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.30% of China Pharma's floating shares are currently sold short.

China Pharma saw a drop in short interest in the month of July. As of July 31st, there was short interest totaling 6,900 shares, a drop of 87.5% from the previous total of 55,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

China Pharma currently has issued a total of 3,262,000 shares. Some of China Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. China Pharma currently has a public float of 2,270,000 shares.

0.30% of China Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to China Pharma: Equillium, Inc. (2.43%), Finch Therapeutics Group, Inc. (0.01%), Imunon, Inc. (12.88%), BioAtla, Inc. (7.56%), 180 Life Sciences Corp. (30.55%), Chemomab Therapeutics Ltd. Sponsored ADR (0.72%), Hoth Therapeutics, Inc. (2.32%), Cadrenal Therapeutics, Inc. (2.39%), Passage Bio, Inc. (3.21%), Synlogic, Inc. (0.49%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), MicroStrategy Incorporated ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks.

Short selling CPHI is an investing strategy that aims to generate trading profit from China Pharma as its price is falling. CPHI shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for China Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CPHI, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CPHI, twice per month. The most recent reporting period available is July, 31 2025.